Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gastin Force is a standardized herbal formulation developed and manufactured by Soho Global Health. It is marketed in Indonesia as a supportive therapy to alleviate symptoms of gastric distress and functional dyspepsia, including stomach pain, bloating, flatulence, and nausea. The product is formulated as an oral suspension containing a synergistic combination of eight herbal extracts: bitter candytuft (Iberis amara), angelica (Angelica sinensis), chamomile (Matricaria chamomilla), caraway (Carum carvi), milk thistle (Silybum marianum), lemon balm (Melissa officinalis), licorice (Glycyrrhiza uralensis), and peppermint (Mentha piperita). These botanical components work in concert to modulate gastrointestinal motility, exert anti-inflammatory effects, and reduce gastric spasms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gastin Force.